Canadian application, no grantCanada
Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes
CA 2499738 A1 · Owner: Dugan, Margaret Han · Inventors: Dugan, Margaret Han; List, Alan
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a method of treating myelodysplastic syndromes comprising administering a therapeutically effective amount of a 4pyridylmethyl-phthalazine derivative to a warm-blooded animal in need thereof.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 23, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 23, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 23, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 23, 2003
GrantedNo grant recorded
Term endedSeptember 23, 2023
Patent numberCA 2499738 A1
Classification (IPC)A61K31/50 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.